Table 2.
Total number | 14a |
Median age (years) | 61 (35–70) |
Gender | 5 Males, 9 females |
Race/ethnicity | 12 Caucasian, 2 Asian |
Karnofsky performance status | |
90% | 5 |
80% | 6 |
70% | 1 |
60% | 2 |
Prior treatment | 2.5 (1–6) |
Primary sites | |
Lung cancer (non-small cell) | |
Colorectal | 2 |
Esophagus | 1 |
Breast | 1 |
Gastric | 1 |
Salivary gland | 1 |
Cervix | 1 |
Unknown | 1 |
Metastatic sites | 3 (1–8) |
Two patients were not evaluable for toxicity